Skip to main content
Fig. 3 | Fluids and Barriers of the CNS

Fig. 3

From: Role of interleukin-6 and interleukin-10 in morphological and functional changes of the blood–brain barrier in hypertriglyceridemia

Fig. 3

Immunostaining and fluorescence intensity of key BBB proteins in endothelial cell cultures following cytokine treatments. a P-glycoprotein, b claudin-5, c occludin, d zonula occludens protein-1 (ZO-1) immunolabeling of wild type (WT) and apolipoprotein B-100 (APOB-100) brain endothelial cell cultures. AU: arbitrary unit. #: significant change between WT and APOB-100 cells (p < 0.05); *: significant change due to cytokine treatment compared to the control group with the same genotype (p < 0.05)

Back to article page

Fluids and Barriers of the CNS

ISSN: 2045-8118